- Home
- MSN vs ERNA Comparison
MSN vs ERNA Comparison
Compare MSN & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSN | ERNA |
|---|---|---|
| Founded | 1948 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 10.2M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MSN | ERNA |
|---|---|---|
| Price | $0.43 | $1.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 80.3K | 52.0K |
| Earning Date | 11-14-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,739,000.00 | $1,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $1.09 |
| 52 Week High | $0.85 | $14.40 |
Technical Indicators
Market Signals| Indicator | MSN | ERNA |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 45.36 |
| Support Level | $0.41 | $1.10 |
| Resistance Level | $0.44 | $1.43 |
| Average True Range (ATR) | 0.03 | 0.10 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 66.11 | 47.62 |
Price Performance
Historical ComparisonAbout MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.